Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01514396 · ClinicalTrials.gov registry record · NA
Skin Incision Adhesive in Pediatrics
A NA study, sponsored by Medline Industries.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT01514396: Completed NA study, sponsored by Medline Industries.
NCT01514396 is a NA study that has completed, run by Medline Industries. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01514396, a NA study, has completed, sponsored by Medline Industries.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of on-label use of Surgiseal™ Tissue Adhesive, a cyanoacrylate-based Surgical Topical Skin Tissue Adhesive in wound closure of the topical skin in children presenting in the Emergency Department (ED).
Primary Outcome
wound closure measured baseline to 14 days
Interventions
- DEVICE Surgiseal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2013-02 |
| Est. Completion | 2014-08 |
| Phase | NA |
What the finished NCT01514396 record still lists
NCT01514396 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Surgiseal is the first listed.
NCT01514396 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01514396 about?
NCT01514396 is a clinical study titled "Skin Incision Adhesive in Pediatrics". The purpose of this study is to evaluate the effectiveness of on-label use of Surgiseal™ Tissue Adhesive, a cyanoacrylate-based Surgical Topical Skin Tissue Adhesive in wound closure of the topical skin in children presenting in the Emergency Department (ED).
What is the current status of trial NCT01514396?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2013-02. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01514396?
The interventions under investigation include: Surgiseal (DEVICE).
Who is sponsoring clinical trial NCT01514396?
This trial is sponsored by Medline Industries, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01514396's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia